Cargando…

C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study

INTRODUCTION: C-reactive protein (CRP) has been shown to be a valuable marker in the diagnosis of infection and in monitoring its response to antibiotics. Our objective was to evaluate serial CRP measurements after prescription of antibiotics to describe the clinical course of Community-Acquired Sep...

Descripción completa

Detalles Bibliográficos
Autores principales: Póvoa, Pedro, Teixeira-Pinto, Armando M, Carneiro, António H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387609/
https://www.ncbi.nlm.nih.gov/pubmed/21762483
http://dx.doi.org/10.1186/cc10313
_version_ 1782237107572441088
author Póvoa, Pedro
Teixeira-Pinto, Armando M
Carneiro, António H
author_facet Póvoa, Pedro
Teixeira-Pinto, Armando M
Carneiro, António H
author_sort Póvoa, Pedro
collection PubMed
description INTRODUCTION: C-reactive protein (CRP) has been shown to be a valuable marker in the diagnosis of infection and in monitoring its response to antibiotics. Our objective was to evaluate serial CRP measurements after prescription of antibiotics to describe the clinical course of Community-Acquired Sepsis admitted to intensive care units (ICU). METHODS: During a 12-month period a multi-center, prospective, observational study was conducted, segregating adults with Community-Acquired Sepsis. Patients were followed-up during the first five ICU days, day of ICU discharge or death and hospital outcome. CRP-ratio was calculated in relation to Day 1 CRP concentration. Patients were classified according to the pattern of CRP-ratio response to antibiotics: fast response if Day 5 CRP-ratio was < 0.4, slow response if Day 5 CRP-ratio was between 0.4 and 0.8, and no response if Day 5 CRP-ratio was > 0.8. Comparison between survivors and non-survivors was performed. RESULTS: A total of 891 patients (age 60 ± 17 yrs, hospital mortality 38%) were studied. There were no significant differences between the CRP of survivors and non-survivors until Day 2 of antibiotic therapy. On the following three days, CRP of survivors was significantly lower (P < 0.001). After adjusting for the Simplified Acute Physiology Score II and severity of sepsis, the CRP course was significantly associated with mortality (OR(CRP-ratio )= 1.03, confidence interval (95%)= (1.02, 1.04), P < 0.001). The hospital mortality of patients with fast response, slow response and no response patterns was 23%, 30% and 41%, respectively (P = 0.001). No responders had a significant increase on the odds of death (OR = 2.5, CI(95% )= (1.6, 4.0), P < 0.001) when compared with fast responders. CONCLUSIONS: Daily CRP measurements after antibiotic prescription were useful as early as Day 3 in identification of Community-Acquired Sepsis patients with poor outcome. The rate of CRP decline during the first five ICU days was markedly associated with prognosis. The identification of the pattern of CRP-ratio response was useful in the recognition of the individual clinical course.
format Online
Article
Text
id pubmed-3387609
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33876092012-07-02 C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study Póvoa, Pedro Teixeira-Pinto, Armando M Carneiro, António H Crit Care Research INTRODUCTION: C-reactive protein (CRP) has been shown to be a valuable marker in the diagnosis of infection and in monitoring its response to antibiotics. Our objective was to evaluate serial CRP measurements after prescription of antibiotics to describe the clinical course of Community-Acquired Sepsis admitted to intensive care units (ICU). METHODS: During a 12-month period a multi-center, prospective, observational study was conducted, segregating adults with Community-Acquired Sepsis. Patients were followed-up during the first five ICU days, day of ICU discharge or death and hospital outcome. CRP-ratio was calculated in relation to Day 1 CRP concentration. Patients were classified according to the pattern of CRP-ratio response to antibiotics: fast response if Day 5 CRP-ratio was < 0.4, slow response if Day 5 CRP-ratio was between 0.4 and 0.8, and no response if Day 5 CRP-ratio was > 0.8. Comparison between survivors and non-survivors was performed. RESULTS: A total of 891 patients (age 60 ± 17 yrs, hospital mortality 38%) were studied. There were no significant differences between the CRP of survivors and non-survivors until Day 2 of antibiotic therapy. On the following three days, CRP of survivors was significantly lower (P < 0.001). After adjusting for the Simplified Acute Physiology Score II and severity of sepsis, the CRP course was significantly associated with mortality (OR(CRP-ratio )= 1.03, confidence interval (95%)= (1.02, 1.04), P < 0.001). The hospital mortality of patients with fast response, slow response and no response patterns was 23%, 30% and 41%, respectively (P = 0.001). No responders had a significant increase on the odds of death (OR = 2.5, CI(95% )= (1.6, 4.0), P < 0.001) when compared with fast responders. CONCLUSIONS: Daily CRP measurements after antibiotic prescription were useful as early as Day 3 in identification of Community-Acquired Sepsis patients with poor outcome. The rate of CRP decline during the first five ICU days was markedly associated with prognosis. The identification of the pattern of CRP-ratio response was useful in the recognition of the individual clinical course. BioMed Central 2011 2011-07-15 /pmc/articles/PMC3387609/ /pubmed/21762483 http://dx.doi.org/10.1186/cc10313 Text en Copyright ©2011 Póvoa et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/2.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Póvoa, Pedro
Teixeira-Pinto, Armando M
Carneiro, António H
C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study
title C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study
title_full C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study
title_fullStr C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study
title_full_unstemmed C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study
title_short C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study
title_sort c-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387609/
https://www.ncbi.nlm.nih.gov/pubmed/21762483
http://dx.doi.org/10.1186/cc10313
work_keys_str_mv AT povoapedro creactiveproteinanearlymarkerofcommunityacquiredsepsisresolutionamulticenterprospectiveobservationalstudy
AT teixeirapintoarmandom creactiveproteinanearlymarkerofcommunityacquiredsepsisresolutionamulticenterprospectiveobservationalstudy
AT carneiroantonioh creactiveproteinanearlymarkerofcommunityacquiredsepsisresolutionamulticenterprospectiveobservationalstudy